Synthesis and evaluation of a conditionally-silent agonist for the α7 nicotinic acetylcholine receptor

被引:36
|
作者
Chojnacka, Kinga [1 ]
Papke, Roger L. [2 ]
Horenstein, Nicole A. [1 ]
机构
[1] Univ Florida, Dept Chem, Gainesville, FL 32611 USA
[2] Univ Florida, Dept Pharmacol & Therapeut, Gainesville, FL 32610 USA
关键词
Silent-agonist; Allosteric modulator; Ion-channel; Nicotinic receptor; POSITIVE ALLOSTERIC MODULATION; ACTIVATION; MECHANISM; LIGANDS; CHANNEL;
D O I
10.1016/j.bmcl.2013.05.039
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
We introduce the term 'silent agonists' to describe ligands that can place the alpha 7 nicotinic acetylcholine receptor (nAChR) into a desensitized state with little or no apparent activation of the ion channel, forming a complex that can subsequently generate currents when treated with an allosteric modulator. KC-1 (5'-phenylanabaseine) was synthesized and identified as a new silent agonist for the alpha 7 nAChR; it binds to the receptor but does not activate alpha 7 nAChR channel opening when applied alone, and its agonism is revealed by co-application with the type II positive allosteric modulator PNU-120596 in the Xenopus oocyte system. The concise synthesis was accomplished in three steps with the C-C bonds formed via Pd-catalyzed mono-arylation and organolithium coupling with N-Boc piperidinone. Comparative structural analyses indicate that a positive charge, an H-bond acceptor, and an aryl ring in a proper arrangement are needed to constitute one class of silent agonist for the alpha 7 nAChR. Because silent agonists may act on signaling pathways not involving ion channel opening, this class of alpha 7 nAChR ligands may constitute a new alternative for the development of alpha 7 nAChR therapeutics. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4145 / 4149
页数:5
相关论文
共 50 条
  • [21] Methadone is a Non-Competitive Antagonist at the α4β2 and α3*Nicotinic Acetylcholine Receptors and an Agonist at the α7 Nicotinic Acetylcholine Receptor
    Talka, Reeta
    Salminen, Outi
    Tuominen, Raimo K.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2015, 116 (04) : 321 - 328
  • [22] Identification of α7 Nicotinic Acetylcholine Receptor Silent Agonists Based on the Spirocyclic Quinuclidine-Δ2-Isoxazoline Scaffold: Synthesis and Electrophysiological Evaluation
    Quadri, Marta
    Matera, Carlo
    Silnovic, Almin
    Pismataro, Maria Chiara
    Horenstein, Nicole A.
    Stokes, Clare
    Papke, Roger L.
    Dallanoce, Clelia
    CHEMMEDCHEM, 2017, 12 (16) : 1335 - 1348
  • [23] EVP-6124, a novel and selective α7 nicotinic acetylcholine receptor partial agonist, improves memory performance by potentiating the acetylcholine response of α7 nicotinic acetylcholine receptors
    Prickaerts, Jos
    van Goethem, Nick P.
    Chesworth, Richard
    Shapiro, Gideon
    Boess, Frank G.
    Methfessel, Christoph
    Reneerkens, Olga A. H.
    Flood, Dorothy G.
    Hilt, Dana
    Gawryl, Maria
    Bertrand, Sonia
    Bertrand, Daniel
    Koenig, Gerhard
    NEUROPHARMACOLOGY, 2012, 62 (02) : 1099 - 1110
  • [24] Stress and the α7 Nicotinic Acetylcholine Receptor
    Hunter, Richard G.
    CURRENT DRUG TARGETS, 2012, 13 (05) : 607 - 612
  • [25] Schizophrenia and the α7 nicotinic acetylcholine receptor
    Martin, Laura F.
    Freedman, Robert
    INTEGRATING THE NEUROBIOLOGY OF SCHIZOPHRENIA, 2007, 78 : 225 - 246
  • [26] Molecular dissection of tropisetron, an α7 nicotinic acetylcholine receptor-selective partial agonist
    Papke, RL
    Schiff, HC
    Jack, BA
    Horenstein, NA
    NEUROSCIENCE LETTERS, 2005, 378 (03) : 140 - 144
  • [27] Pilot study of an α7 nicotinic acetylcholine receptor agonist adjuvant therapeutic strategy for schizophrenia
    Deutsch, Stephen I.
    Schwartz, Barbara L.
    Schooler, Nina R.
    Rosse, Richard B.
    Mastropaolo, John
    Gaskins, Brooke L.
    NEUROPSYCHOPHARMACOLOGY, 2006, 31 : S250 - S250
  • [28] Effects of α7 nicotinic acetylcholine receptor agonist against α-synuclein-induced neurotoxicity
    Takizawa, Shinnosuke
    Ohuchi, Kazuki
    Fujimaki, Ayaka
    Ito, Taisei
    Murakami, Takanori
    Kurita, Hisaka
    Inden, Masatoshi
    NEUROSCIENCE LETTERS, 2024, 823
  • [29] Alpha7 nicotinic acetylcholine receptor agonist improves survival during endotoxemia
    Chen, F.
    Cai, B.
    Dong, W.
    Deitch, E. A.
    Ulloa, L.
    SHOCK, 2008, 29 : 80 - 80
  • [30] APN1125: A clinical stage α7 nicotinic acetylcholine receptor partial agonist
    Koelsch, Gerald
    Detke, Michael J.
    Stevens, Karen E.
    Meltzer, Leonard T.
    Terry, Alvin V., Jr.
    Callahan, Patrick M.
    Yoshimura, Ryan F.
    Bilcer, Geoffrey
    Anderson, Paul C.
    Ng, John
    Ng, Raymond
    Kelly, Terence A.
    BIOCHEMICAL PHARMACOLOGY, 2015, 97 (04) : 636 - 636